IOVS Hypertension
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Topper, J. E.
Right arrow Articles by Brubaker, R. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Topper, J. E.
Right arrow Articles by Brubaker, R. F.

Investigative Ophthalmology & Visual Science, Vol 26, 1315-1319, Copyright © 1985 by Association for Research in Vision and Ophthalmology


ARTICLES AND REPORTS

Effects of timolol, epinephrine, and acetazolamide on aqueous flow during sleep

JE Topper and RF Brubaker

The effects of timolol, epinephrine, and acetazolamide on the rate of flow of aqueous humor through the anterior chamber of awake and sleeping human subjects was studied. Timolol reduced the rate in awake subjects but not sleeping subjects. Epinephrine increased the rate in sleeping subjects to a greater extent than in awake subjects. Acetazolamide reduced the rate of flow in awake subjects or epinephrine- stimulated subjects. Acetazolamide reduced the rate of flow slightly below the basal rate observed during sleep, but the reduction was small and not statistically significant. The authors propose that the diurnal fluctuation of the rate of aqueous humor flow in humans is driven by changes in the concentration of endogenous epinephrine available to the ciliary epithelia.


This article has been cited by other articles:


Home page
IOVSHome page
L. Quaranta, S. Miglior, I. Floriani, T. Pizzolante, and A. G. P. Konstas
Effects of the Timolol-Dorzolamide Fixed Combination and Latanoprost on Circadian Diastolic Ocular Perfusion Pressure in Glaucoma
Invest. Ophthalmol. Vis. Sci., October 1, 2008; 49(10): 4226 - 4231.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
N. McLaren, D. M. Reed, D. C. Musch, C. A. Downs, M. E. Higashi, C. Santiago, P. A. Radenbaugh, R. R. Allingham, J. E. Richards, and S. E. Moroi
Evaluation of the beta2-Adrenergic Receptor Gene as a Candidate Glaucoma Gene in 2 Ancestral Populations
Arch Ophthalmol, January 1, 2007; 125(1): 105 - 111.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
L. Quaranta, F. Gandolfo, R. Turano, F. Rovida, T. Pizzolante, A. Musig, and E. Gandolfo
Effects of Topical Hypotensive Drugs on Circadian IOP, Blood Pressure, and Calculated Diastolic Ocular Perfusion Pressure in Patients with Glaucoma.
Invest. Ophthalmol. Vis. Sci., July 1, 2006; 47(7): 2917 - 2923.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
R. N. Weinreb and J. H. K. Liu
Nocturnal rhythms of intraocular pressure.
Arch Ophthalmol, February 1, 2006; 124(2): 269 - 270.
[Full Text] [PDF]


Home page
Arch OphthalmolHome page
N. Orzalesi, L. Rossetti, A. Bottoli, E. Fumagalli, and P. Fogagnolo
The Effect of Latanoprost, Brimonidine, and a Fixed Combination of Timolol and Dorzolamide on Circadian Intraocular Pressure in Patients With Glaucoma or Ocular Hypertension
Arch Ophthalmol, April 1, 2003; 121(4): 453 - 457.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
L. Z. Bito
A New Approach to the Medical Management of Glaucoma, from the Bench to the Clinic, and Beyond: The Proctor Lecture
Invest. Ophthalmol. Vis. Sci., May 1, 2001; 42(6): 1126 - 1133.
[Full Text]


Home page
Arch OphthalmolHome page
L.-I. Larsson
Aqueous Humor Flow in Normal Human Eyes Treated With Brimonidine and Timolol, Alone and in Combination
Arch Ophthalmol, April 1, 2001; 119(4): 492 - 495.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
N. Orzalesi, L. Rossetti, T. Invernizzi, A. Bottoli, and A. Autelitano
Effect of Timolol, Latanoprost, and Dorzolamide on Circadian IOP in Glaucoma or Ocular Hypertension
Invest. Ophthalmol. Vis. Sci., August 1, 2000; 41(9): 2566 - 2573.
[Abstract] [Full Text]


Home page
Arch OphthalmolHome page
T. L. Maus, C. Nau, and R. F. Brubaker
Comparison of the Early Effects of Brimonidine and Apraclonidine as Topical Ocular Hypotensive Agents
Arch Ophthalmol, May 1, 1999; 117(5): 586 - 591.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1985 by the Association for Research in Vision and Ophthalmology